ARQT Earnings

Quarterly EPS
$-0.09
Q4 2024
$-0.20
Q1 2025
$-0.13
Q2 2025
$0.06
Q3 2025
$0.14
Q4 2025
$-0.09
Q1 2026
$0.11
Q2 2026
$0.07
Q3 2026
Latest Revenue143.9M
Latest Net Income8.8M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026$0.07143.9M8.8M+45.1%+16.7%
Q2 2026$0.11129.9M15.0M+59.3%+184.6%
Q1 2026-$0.09105.4M-11295000+60.1%+55.0%
Q4 2025$0.14129.5M17.4M+81.5%+255.6%
Q3 2025$0.0699.2M7.4M+121.7%+118.2%
Q2 2025-$0.1381.5M-15886000+164.1%+69.0%
Q1 2025-$0.2065.8M-25060000+32.8%+37.5%
Q4 2024-$0.0971.4M-10788000+427.6%+87.3%
Q3 2024-$0.3344.8M-41537000——
Q2 2024-$0.4230.9M-52332000——
Q1 2024-$0.3249.6M-35382000——
Q4 2023-$0.7113.5M-66284000——
Arcutis Biotherapeutics (ARQT) — Earnings